www.rxwiki.com
In the search for an effective treatment for recurrent miscarriage, one option may have fallen short.
In the first study to provide a definitive answer to more than 60 years of uncertainty, a team of researchers from the UK found that progesterone therapy did not improve outcomes for women with unexplained recurrent miscarriage (URM). URM is a condition when a woman has three or more clinical pregnancy losses (miscarriages) before she completes her first trimester.
Although the results of the PROMISE trial may be disappointing to many, this finding will allow researchers to direct their efforts toward exploring more beneficial treatment options for URM.
